Scalable Operating Models

An operating model that holds when markets, products or clients grow. Or a clear north star for one that has grown too expensive, too slow or too uneven in quality.

I help you decide what to run globally, what stays with the markets and where partners can do the work better. Content production can run through shared hubs while markets retain local decision rights and Medical retains its independent approvals. Funding, adoption and responsibilities across business, IT, procurement and finance determine whether the model works in practice.

How to work with me

Ongoing transformation support. I work with the sponsor and the teams that have to make the change stick. We agree what the new model must deliver, who owns the decisions and how we will know it is working. I stay involved through design, rollout and stabilisation.
Operating Model Check. I examine where your current model breaks first as you grow, or where it has become too expensive, too slow or too uneven in quality, and what it needs to keep pace with the business. A short written read-out sets out the three to five things that matter.
North Star and Blueprint. I set out the target operating model and the blueprint to get there: process and handoffs, make or buy, locations, owners, governance, funding, incentives and the sequence. We agree which capabilities are shared, what markets retain and how teams will adopt the model.
Executive workshops. Focused sessions with your leadership team on the operating model and its governance, and on what automation and AI change in how the work gets done. They work well before a redesign starts, or when the team needs to agree where automation should come first. You leave with the decisions that matter, the trade-offs and who owns each one.

Who it is for

  • Established pharma: commercial, medical and global services organisations that need to consolidate, move work near- or offshore, or prepare for automation and AI at scale.
  • Commercial-stage biotech and mid-sized pharma: teams preparing for the next markets or indication.
  • Suppliers to pharma: teams that need to deliver reliably across pharma markets.

Global services platform

I grew a small nearshore team in 2019 into a global services platform serving 100+ markets in under six years, with €75m+ annual operating spend. Commercial and medical operations worked in one operating model, with hubs in Europe and India including a nearshore delivery centre of 350+ people.

The delivery ecosystem counted 1,000+ internal and external professionals. The platform ran at around 50% lower structural cost than the less centralised model it replaced. I stabilised the operation, put a management team in place and handed over a running operating model.

What can follow: Profitable Growth, so the model keeps paying for itself as volume grows.

Next step: email me with the organisation you want to change.

michael@kurradvisory.com